Chargement en cours...
Use of dapagliflozin in patients with advanced diabetic kidney disease
Sodium-glucose cotransporter-2 (SGLT2) inhibitors are effective for overweight diabetic patients through the induction of glucosuria. However, SGLT2 inhibitors are not recommended for patients with advanced chronic kidney disease (CKD) because they may aggravate renal function and thus become less e...
Enregistré dans:
| Publié dans: | Kidney Res Clin Pract |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Korean Society of Nephrology
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6147181/ https://ncbi.nlm.nih.gov/pubmed/30254854 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.23876/j.krcp.2018.37.3.292 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|